Recap: Evoke Pharma Q4 Earnings
Recap: Evoke Pharma Q4 Earnings
Evoke Pharma (NASDAQ:EVOK) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:10 PM.
Evoke Pharma（纳斯达克股票代码：EVOK）于2024年3月14日星期四下午4点10分公布了其第四季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Evoke Pharma missed estimated earnings by -18.0%, reporting an EPS of $-0.59 versus an estimate of $-0.5.
Evoke Pharma报告每股收益为-0.59美元，未达到预期收益-18.0％，而预期为-0.59美元。
Revenue was up $880 thousand from the same period last year.
收入比去年同期增长了88万美元。
Past Earnings Performance
过去的收益表现
Last quarter the company beat on EPS by $0.11 which was followed by a 2.0% drop in the share price the next day.
上个季度，该公司的每股收益高出0.11美元，随后第二天股价下跌了2.0％。
Here's a look at Evoke Pharma's past performance:
以下是Evoke Pharma过去的表现：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.62 | -0.73 | -0.58 | -0.53 |
| EPS Actual | -0.51 | -0.56 | -0.67 | -0.54 |
| Revenue Estimate | 1.26M | 1.10M | 1.00M | 890K |
| Revenue Actual | 1.56M | 1.13M | 810K | 796K |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.62 | -0.73 | -0.58 | -0.53 |
| 实际每股收益 | -0.51 | -0.56 | -0.67 | -0.54 |
| 收入估算 | 1.26 米 | 1.10 米 | 1.00M | 890 K |
| 实际收入 | 1.56 米 | 1.13 米 | 810K | 796K |
To track all earnings releases for Evoke Pharma visit their earnings calendar here.
要追踪Evoke Pharma的所有财报，请在此处访问他们的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。
译文内容由第三方软件翻译。